Meningitis News and Research

Latest Meningitis News and Research

Octapharma USA announces FDA approval of cutaquig 16.5% for pediatric PI patients

Octapharma USA today announced the U.S. Food & Drug Administration has approved cutaquig [Immune globulin, Subcutaneous (Human)-hipp, 16.5% Solution] for the treatment of pediatric patients age 2 and older with primary humoral immunodeficiency (PI). The FDA previously approved cutaquig for adults with PI.

7 Dec 2021

Single-dose HPV vaccine could be effective for preventing cervical cancer

A single dose of human papillomavirus (HPV) vaccine could be effective for preventing cervical cancer, raising hopes of fighting the disease in Sub-Saharan Africa, a conference has heard.

1 Dec 2021

Study shows SARS-CoV-2 can infect and replicate in human iPSC-derived neurons

In a study recently published on the bioRxiv preprint server, researchers attempted to further increase the scope of previous studies in examining SARS-CoV-2 infection of human CNS resident cells.

22 Nov 2021

UC researchers engineer new probiotic to target and break down cancer cell defenses

Bacteria generally have a bad reputation, as people first think of certain strains that can cause serious illnesses like pneumonia or meningitis. However, there are many helpful bacteria, known as probiotics, that assist the body in different ways.

21 Nov 2021

Trial positions single-dose HPV vaccination as a high impact public health intervention

In the push to eliminate cervical cancer, researchers delivered hopeful news Nov. 17 at the 34th International Papillomavirus Conference in Toronto.

20 Nov 2021

Researchers identify compounds that tackle fungal infections in a new way

Current medications aren't particularly effective against fungi. The situation is becoming more challenging because these organisms are developing resistance to antimicrobial treatments, just as bacteria are.

17 Nov 2021

Neurological complications are higher with SARS-CoV-2 infection than COVID vaccine, study finds

Research published in the journal Nature Medicine suggests a risk for neurological complications after the first shot of a COVID-19 vaccine. However, the likelihood of developing neurological complications remains far greater among people infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

31 Oct 2021

COVID-19 and subacute neuropsychiatric symptoms in adolescents

A new paper discusses neurologic symptoms in children with COVID-19.

27 Oct 2021

Clinical trial shows no benefit of tamoxifen in treating deadly fungal meningitis

Hopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by clinical trial results published in eLife.

26 Oct 2021

New data reveals safety, efficacy of nusinersen drug delivery method for SMA patients with advanced disease

A recently published paper details the safety and efficacy of nusinersen administration via a subcutaneous intrathecal catheter system (SIC) for SMA patients with advanced disease.

25 Oct 2021

The neurological effects of COVID-19

What is the relationship between COVID-19 and the brain? A new review published in Tropical Biomedicine summarizes the key findings on how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes severe COVID-19 infection, disrupts brain activity and produces a range of long-term neurological disorders.

10 Oct 2021

Large study of COVID vaccine side effects in Sweden

Recently, researchers from Sweden reported population-based, age- and sex-specific background incidence rates of conditions that represent potential COVID-19 vaccine adverse events of special interest (AESI) in the general Swedish population with the help of registered data. This study is published on the medRxiv* preprint server.

6 Oct 2021

WHO and partners launch the first ever global strategy to defeat meningitis

Today, the World Health Organization and partners launched the first ever global strategy to defeat meningitis - a debilitating disease that kills hundreds of thousands of people each year.

1 Oct 2021

Diverse vaccine attitudes amongst UK healthcare workers suggest hesitancy may remain after vaccine acceptance

In a recent paper, the phenomenon of vaccine hesitancy is further explored amongst UK healthcare workers.

30 Sep 2021

Kawasaki Disease presents a growing threat to UK children’s heart health

Today, on World Heart Day, Societi, the UK Kawasaki Disease Foundation is campaigning to protect tiny hearts — by highlighting the urgent need for awareness of Kawasaki Disease – the leading cause of acquired heart disease in U.K. children.

29 Sep 2021

Penn scientists win 2021 Lasker Award for the discovery of therapeutic mRNA technology

As mRNA-based SARS-CoV-2 vaccines are deployed to protect hundreds of millions of people across the world and point the way to end the deadly global COVID-19 pandemic, the University of Pennsylvania scientists whose prescient discovery science effort laid the foundation for swift vaccine development have been awarded the 2021 Lasker~DeBakey Clinical Medical Research Award.

24 Sep 2021

Study sheds light on neurologic symptoms caused by SARS-CoV-2 infection

Researchers in Australia and Finland have provided important insights into how infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – might affect nervous system circuitries and cause neurologic symptoms.

6 Sep 2021

Researchers explore how to optimally control diseases in prison population using rapid tests

The use of rapid tests to screen for diseases in prisons could enable the diagnosis of asymptomatic individuals and reduce the spread of infection. Victor Riquelme, Pedro Gajardo, and Diego Vicencio (all from the Universidad Técnica Federico Santa María in Chile) recently explored how to optimally control a communicable disease inside a prison population using inexpensive, low-complexity rapid tests that personnel can administer with only basic training.

25 Aug 2021

Human milk oligosaccharides may help treat or prevent bacterial infections in newborns and adults

Bacteria known as group B Streptococcus (GBS) are a common cause of blood infections, meningitis and stillbirth in newborns. Although GBS infections can often be treated or prevented with antibiotics, the bacteria are becoming increasingly resistant.

23 Aug 2021

Researchers create a novel strategy for developing an effective TB vaccine

Innovators at Purdue University and Houston Methodist Research Institute have created a novel strategy for developing an effective vaccine for a widespread form of tuberculosis.

20 Aug 2021

Meningitis News and Research

Latest Meningitis News and Research

Octapharma USA announces FDA approval of cutaquig 16.5% for pediatric PI patients

Single-dose HPV vaccine could be effective for preventing cervical cancer

Study shows SARS-CoV-2 can infect and replicate in human iPSC-derived neurons

UC researchers engineer new probiotic to target and break down cancer cell defenses

Trial positions single-dose HPV vaccination as a high impact public health intervention

Researchers identify compounds that tackle fungal infections in a new way

Neurological complications are higher with SARS-CoV-2 infection than COVID vaccine, study finds

COVID-19 and subacute neuropsychiatric symptoms in adolescents

Clinical trial shows no benefit of tamoxifen in treating deadly fungal meningitis

New data reveals safety, efficacy of nusinersen drug delivery method for SMA patients with advanced disease

The neurological effects of COVID-19

Large study of COVID vaccine side effects in Sweden

WHO and partners launch the first ever global strategy to defeat meningitis

Diverse vaccine attitudes amongst UK healthcare workers suggest hesitancy may remain after vaccine acceptance

Kawasaki Disease presents a growing threat to UK children’s heart health

Penn scientists win 2021 Lasker Award for the discovery of therapeutic mRNA technology

Study sheds light on neurologic symptoms caused by SARS-CoV-2 infection

Researchers explore how to optimally control diseases in prison population using rapid tests

Human milk oligosaccharides may help treat or prevent bacterial infections in newborns and adults

Researchers create a novel strategy for developing an effective TB vaccine

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Meningitis News and Research

Latest Meningitis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in